Eli Lilly EBITDA 2010-2024 | LLY

Eli Lilly EBITDA for the quarter ending June 30, 2024 was $4.564B, a 83.15% increase year-over-year.

  • Eli Lilly 2023 EBITDA was 7.985B, a 7.68% decline from 2022.
  • Eli Lilly 2022 EBITDA was 8.65B, a 9.43% increase from 2021.
  • Eli Lilly 2021 EBITDA was 7.905B, a 7.08% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Eli Lilly EBITDA 2010-2024 | LLY

  • Eli Lilly 2023 EBITDA was 7.985B, a 7.68% decline from 2022.
  • Eli Lilly 2022 EBITDA was 8.65B, a 9.43% increase from 2021.
  • Eli Lilly 2021 EBITDA was 7.905B, a 7.08% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B